XNAS · ARDX
-0.55% · -$0.0300 · Vol 2.2M
Market closed · last close 4:00 PM ET · price as of 17:44:49 ET
Ardelyx, Inc.

Ardelyx, Inc.

PHARMACEUTICAL PREPARATIONS
$5.40
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is ARDX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for ARDX are being assembled.
About Ardelyx, Inc.
PHARMACEUTICAL PREPARATIONS
Listed since
2014
Employees
489
Country
US

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$5.43
Day high
$5.45
Day low
$5.33
Previous close
$5.43
52W high
$6.25
-13.60% from high
52W low
$5.06
28% of range
Market cap
$1.3B
EPS
$-0.2500
Shares out
247M
Volume
2.2M
VWAP
$5.37
Price history computed in-house
1W
+2.18%
1M
-7.38%
SMA 50 $5.65 · below
SMA 200 $5.65 · below
52W position 28%
Veridion warehouse edge

Warehouse intelligence for ARDX.

Veridion Score
60
0: 611: 522: 423: 504: 885: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

ARDX insider activity

Ardelyx, Inc.

Score
Coverage building
Pressure
Net selling
Filings
73
Buys / sells
9 / 64
Net value
-$2.4M
Insiders
11
Named filers
WA
Williams Laura A
Insider
Leadership
RM
RAAB MICHAEL
Insider
Leadership
HS
Hohenleitner Susan
Insider
Leadership
Cluster

2 insiders bought in the last 90 days

Net pressure

Net selling: -$2.4M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-06-222026-06-18Williams Laura AInsidersell$5.9981,898378,195$490KSEC Form 4
2026-06-222026-06-18Williams Laura AInsiderbuy$0.9931,000460,093$31KSEC Form 4
2026-06-172026-06-15RAAB MICHAELInsidersell$5.6741,6661,699,200$236KSEC Form 4
2026-06-172026-06-15RAAB MICHAELInsiderbuy$0.9920,8331,740,866$21KSEC Form 4
2026-05-222026-05-21Hohenleitner SusanInsidersell$6.271,455229,078$9KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 68 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

ARDX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ARDX in this window.
Lobbying spend

ARDX lobbying filings, year to date.

Registered lobbying filings matched to Ardelyx, Inc..

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ARDX in this window.
Latest news · ARDX
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for ARDX.
Options
Sovereign unlock shows live options positioning for ARDX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.